FDA Inspection 1052408 — Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site)
The FDA completed an inspection of Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) on April 17, 2018 in Jinan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 17, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinan (China)